Table 1.
Patient characteristics
| SSc (n = 24) | |
|---|---|
| Demographics | |
| Age (years) | |
| Median | 54 |
| Range | 30–81 |
| Sex | |
| Female | 15 (63%) |
| Male | 9 (38%) |
| Disease characteristics | |
| SSc subtype | |
| Limited cutaneous SSc | 14 (58%) |
| Diffuse cutaneous SSc | 10 (42%) |
| Disease duration (years) | |
| Median | 8 |
| Range | 1.2–24 |
| Modified Rodnan skin score | |
| Median | 8 |
| Range | 0–44 |
| Autoantibodies | |
| Antinuclear antibodies (ANA) | 20 (83%) |
| Anti-Scl-70 antibodies | 12 (50%) |
| Anticentromer antibodies (ACA) | 6 (25%) |
| Pretreatment | |
| Cyclophosphamide | 4 (17%) |
| Mycophenolate mofetil | 2 (8%) |
| Stem cell transplant (> 10 years before blood draw) | 2 (8%) |
| Immunosuppressive therapy at time of blood draw | |
| None | 18 (75%) |
| Prednisolone | 2 (8%) |
| Mycophenolate mofetil | 2 (8%) |
| Methotrexate | 3 (13%) |